Literature DB >> 21763069

Local convection-enhanced delivery of chemotherapeutic agent transiently opens blood-brain barrier and improves efficacy of systemic chemotherapy in intracranial xenograft tumor model.

Taigen Nakamura1, Ryuta Saito, Shin-Ichiro Sugiyama, Yukihiko Sonoda, Toshihiro Kumabe, Teiji Tominaga.   

Abstract

Recently, local chemotherapy proved its efficacy against malignant gliomas. Under the hypothesis that local delivery of chemotherapeutic agents into the brain parenchyma induce opening of the blood-brain barrier (BBB), we evaluated the opening of BBB after convection-enhanced delivery of nimustine hydrochloride into the brain parenchyma. Local convection-enhanced delivery of nimustine hydrochloride transiently opened the BBB from about 7-12 days after delivery in normal rodent brain. Systemic chemotherapy during this period of BBB disruption had synergistic effects resulting in prolonged survival of tumor-bearing rats. The present strategy may provide a new approach for glioma chemotherapy.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21763069     DOI: 10.1016/j.canlet.2011.06.018

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  5 in total

1.  EXPLORING THE ANTITUMOR EFFECT OF VIRUS IN MALIGNANT GLIOMA.

Authors:  Dipongkor Saha; Seemin S Ahmed; Samuel D Rabkin
Journal:  Drugs Future       Date:  2015       Impact factor: 0.148

2.  Phase 1 clinical trial of intratumoral reovirus infusion for the treatment of recurrent malignant gliomas in adults.

Authors:  Kimberly P Kicielinski; E Antonio Chiocca; John S Yu; George M Gill; Matt Coffey; James M Markert
Journal:  Mol Ther       Date:  2014-02-20       Impact factor: 11.454

Review 3.  Identifying new small molecule anti-invasive compounds for glioma treatment.

Authors:  Jennifer Munson; Michael Bonner; Levi Fried; Jonathan Hofmekler; Jack Arbiser; Ravi Bellamkonda
Journal:  Cell Cycle       Date:  2013-07-15       Impact factor: 4.534

4.  Phase I trial of convection-enhanced delivery of nimustine hydrochloride (ACNU) for brainstem recurrent glioma.

Authors:  Ryuta Saito; Masayuki Kanamori; Yukihiko Sonoda; Yoji Yamashita; Kenichi Nagamatsu; Takaki Murata; Shunji Mugikura; Toshihiro Kumabe; Eva Wembacher-Schröder; Rowena Thomson; Teiji Tominaga
Journal:  Neurooncol Adv       Date:  2020-03-26

Review 5.  Surgicel application in intracranial hemorrhage surgery contributed to giant-cell granuloma in a patient with hypertension: case report and review of the literature.

Authors:  Bowen Lin; Hongfa Yang; Mengzhao Cui; Ye Li; Jinlu Yu
Journal:  World J Surg Oncol       Date:  2014-04-21       Impact factor: 2.754

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.